Cancer and Metastasis Reviews

, Volume 29, Issue 1, pp 5–14 | Cite as

Natural history of bronchial preinvasive lesions

  • Taichiro Ishizumi
  • Annette McWilliams
  • Calum MacAulay
  • Adi Gazdar
  • Stephen Lam
Article

Abstract

Preinvasive bronchial lesions defined as dysplasia and carcinoma in situ (CIS) have been considered as precursors of squamous cell carcinoma of the lung. The risk and rate of progression of preinvasive lesions to invasive squamous cell carcinoma as well as the mechanism of progression or regression are incompletely understood. While the evidence for the multistage, stepwise progression model is weak with relatively few documented lesions that progress through various grades of dysplasia to CIS and then to invasive carcinoma, the concept of field carcinogenesis is strongly supported. The presence of high-grade dysplasia or CIS is a risk marker for lung cancer both in the central airways and peripheral lung. Genetic alterations such as loss of heterozygosity in chromosome 3p or chromosomal aneusomy as well as host factors such as the inflammatory load and levels of anti-inflammatory proteins in the lung influence the progression or regression of preinvasive lesions. CIS is different than severe dysplasia at the molecular level and has different clinical outcome. Molecular analysis of dysplastic lesions that progress to CIS or invasive cancer and rare lesions that progress rapidly from hyperplasia or metaplasia to CIS or invasive cancer will shed light on the key molecular determinants driving development to an invasive phenotype versus those associated with tobacco smoke damage.

Keywords

Preinvasive lesions Natural history Lung cancer 

References

  1. 1.
    Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74–108.CrossRefGoogle Scholar
  2. 2.
    Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225–249.CrossRefGoogle Scholar
  3. 3.
    Nakamura, H., Kawasaki, N., Hagiwara, M., Ogata, A., Saito, M., Konaka, C., et al. (2001). Early hilar lung cancer—risk for multiple lung cancers and clinical outcome. Lung Cancer, 33, 51–57.CrossRefPubMedGoogle Scholar
  4. 4.
    Kennedy, T. C., McWilliams, A., Edell, E., Sutedja, T., Downie, G., Yung, R., et al. (2007). Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 132, 221S–233S.CrossRefPubMedGoogle Scholar
  5. 5.
    Rami-Porta, R., Ball, D., Crowley, J., Girous, D. J., Jett, J., Travis, W. D., et al. (2007). The IASLC lung cancer staging project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol, 2, 593–602.CrossRefPubMedGoogle Scholar
  6. 6.
    Lam, S., MacAulay, C., Hung, J., LeRiche, J., Profio, A. E., & Palcic, B. (1993). Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg, 105, 1035–1040.PubMedGoogle Scholar
  7. 7.
    Lee, P., van den Berg, R., Lam, S., et al. (2009). Color fluorescence ratio for detection of bronchial dysplasia and carcinoma in situ. Clin Cancer Res, 15(14), 4700–4705.CrossRefPubMedGoogle Scholar
  8. 8.
    Lam, S. (2008). Detection of preneoplastic lesions. In J. A. Roth, J. D. Cox, & W. K. Hong (Eds.), Lung cancer (3rd ed., pp. 99–110). Malden: Blackwell Science.Google Scholar
  9. 9.
    Kelloff, G. J., Lippman, S. M., Dannenberg, A., Sigman, C. C., Pearce, H. L., Reid, B. J., et al. (2006). Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer—a plan to move forward. Clin Cancer Res, 12(12), 3661–3697.CrossRefPubMedGoogle Scholar
  10. 10.
    Wistuba, I. I., & Gazdar, A. F. (2006). Lung cancer preneoplasia. Annu Rev Pathol Mech Dis, 1, 331–348.CrossRefGoogle Scholar
  11. 11.
    Lam, S., Standish, B., Baldwin, C., McWilliams, A., leRiche, J., Gazdar, A., et al. (2008). In vivo optical coherence tomography imaging of preinvasive bronchial lesions. Clin Cancer Res, 14, 2006–2011.CrossRefPubMedGoogle Scholar
  12. 12.
    Saccomanno, G. (1982). Carcinoma in-situ of the lung: Its development, detection, and treatment. Semin Respir Med, 4(2), 156–160.CrossRefGoogle Scholar
  13. 13.
    Auerbach, O., Stout, A. P., Hammond, E. C., & Garfinkel, L. (1961). Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med, 265, 253–267.PubMedCrossRefGoogle Scholar
  14. 14.
    Auerbach, O., Saccomanno, G., Kuschner, M., Brown, R. D., & Garfinkel, L. (1978). Histologic findings in the tracheobronchial tree of uranium miners and non-miners with lung cancer. Cancer, 42, 483–489.CrossRefPubMedGoogle Scholar
  15. 15.
    Hirsch, F. R., Franklin, W. A., Gazdar, A. F., & Bunn, P. A., Jr. (2001). Early detection of lung cancer: Clinical perspectives of recent advances in biology and radiology. Clin Cancer Res, 7, 5–22.PubMedGoogle Scholar
  16. 16.
    Travis, W. D., Brambilla, E., Muller-Hermelink, H. K., & Harris, C. C. (2004). Pathology and genetics: tumors of the lung, pleura, thymus and heart. World Health Organization Classification of Tumours (pp. 9–124). Lyon: IARC.Google Scholar
  17. 17.
    Keith, R., Miller, Y., Gemmill, R., Drabkin, H., Dempsey, E., Kennedy, T., et al. (2000). Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res, 6, 1616–1625.PubMedGoogle Scholar
  18. 18.
    Venmans, B. J., van der Linden, H. C., Elbers, H. R., van Boxem, T. J., Smit, E. F., Postmus, P. E., et al. (2000). Observer variability in histologic reporting of bronchial biopsy specimens. J Bronchol, 7, 210–214.CrossRefGoogle Scholar
  19. 19.
    Nicholson, A. G., Perry, L. J., Cury, O. M., Jackson, P., McCormick, C. M., Corrin, B., et al. (2001). Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation. Histopathology, 38, 202–208.CrossRefPubMedGoogle Scholar
  20. 20.
    Guillaud, M., leRiche, J., Daw, C., Korbelik, J., Coldman, A., Wistuba, I. I., et al. (2005). Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: Correlation with genetic damage and cancer development. Cytometry Part A, 63A(1), 34–40.CrossRefGoogle Scholar
  21. 21.
    Nasiell, M., Auer, G., & Kato, H. (1987). Cytological studies in man and animals on the development of bronchogenic carcinoma. In E. M. McDowell (Ed.), Lung carcinomas (pp. 207–242). Edinburgh: Churchill Livingstone.Google Scholar
  22. 22.
    Saccomanno, G., Archer, V. E., Auerbach, O., Saunders, R. P., & Brennan, L. M. (1974). Development of carcinoma of the lung as reflected in exfoliated cells. Cancer, 33, 256–270.CrossRefPubMedGoogle Scholar
  23. 23.
    Frost, J. K., Ball, W. C., Jr., Levin, M. L., Tockman, M. S., Erozan, Y. S., Gupta, P. K., et al. (1986). Sputum cytopathology: Use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med, 28, 692–703.CrossRefPubMedGoogle Scholar
  24. 24.
    Risse, E. K. J., Vooijs, G. P., & van’t Hof, M. A. (1988). Diagnostic significance of “severe dysplasia” in sputum cytology. Acta Cytologica, 32, 629–634.PubMedGoogle Scholar
  25. 25.
    Nasiell, M. (1966). Metaplasia and atypical metaplasia in the bronchial epithelium: A histopathologic and cytopathologic study. Acta Cytologica, 10, 421–427.Google Scholar
  26. 26.
    Band, P. R., Feldstein, M., & Saccomanno, G. (1986). Reversibility of bronchial marked atypia. Implication for chemoprevention. Cancer Detection and Prevention, 9, 157–160.PubMedGoogle Scholar
  27. 27.
    Breuer, R. H., Pasic, A., Smit, E. F., van Vliet, E., Vonk Noordegraaf, A., Risse, E. J., et al. (2005). The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res, 11, 537–543.PubMedGoogle Scholar
  28. 28.
    Lam, S., LeRiche, J. C., Zheng, Y., Coldman, A., MacAulay, C., Hawk, E., et al. (1999). Sex-related differences in bronchial epithelial changes associated with tobacco smoking. J Natl Cancer Inst, 91(8), 691–696.CrossRefPubMedGoogle Scholar
  29. 29.
    Lam, S., MacAulay, C., leRiche, J., & Palcic, B. (2000). Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer, 89(11 Suppl), 2468–2473.CrossRefPubMedGoogle Scholar
  30. 30.
    Lam, S., Kennedy, T., Unger, M., Miller, Y. E., Gelmont, D., Rusch, V., et al. (1998). Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest, 113(3), 696–702.CrossRefPubMedGoogle Scholar
  31. 31.
    Hirsch, F. R., Prindiville, S. A., Miller, Y. E., Franklin, W. A., Dempsey, E. C., Murphy, J. R., et al. (2001). Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: A randomized study. J Natl Cancer Inst, 93(18), 1385–1391.CrossRefPubMedGoogle Scholar
  32. 32.
    Edell, E., Lam, S., Pass, H., Miller, Y. E., Sutedja, T., Kennedy, T., et al. (2009). Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: An international, multi-center clinical trial. J Thorac Oncol, 4(1), 49–54.PubMedGoogle Scholar
  33. 33.
    Häussinger, K., Becker, H., Stanzel, F., Kreuzer, A., Schmidt, B., Strausz, J., et al. (2005). Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: A European randomized controlled multicentre trial. Thorax, 60(6), 496–503.CrossRefPubMedGoogle Scholar
  34. 34.
    Ernst, A., Simoff, P., Mathur, P., Yung, R., & Beamis, J. (2005). D-Light autofluorescence in the detection of premalignant airway changes; a multicenter trial. J Bronchol, 12, 133–138.CrossRefGoogle Scholar
  35. 35.
    Venmans, B., van Boxem, A., Smit, E., Postmus, P., & Sutedja, T. (2000). Outcome of bronchial carcinoma in-situ. Chest, 117, 1572–1576.CrossRefPubMedGoogle Scholar
  36. 36.
    Moro-Sibilot, D., Fievet, F., Jeanmart, M., Lantuejoul, S., Arbib, F., Laverribre, M. H., et al. (2004). Clinical prognostic indicators of high-grade pre-invasive bronchial lesions. Eur Respirology Journal, 24, 24–29.CrossRefGoogle Scholar
  37. 37.
    Bota, S., Auliac, J. B., Paris, C., Metayer, J., Sesboue, R., Nouvet, G., et al. (2001). Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. American Journal of Respiratory and Critical Care Medicine, 164(9), 1688–1693.PubMedGoogle Scholar
  38. 38.
    Salaun, M., Sesboue, R., Moreno-Swire, S., Metayer, J., Bota, S., Bourguignon, J., et al. (2008). Molecular predictive factors for progression of high-grade preinvasive bronchial lesions. American Journal of Respiratory and Critical Care Medicine, 177, 880–886.CrossRefPubMedGoogle Scholar
  39. 39.
    Salaun, M., Bota, S., & Thiberville, L. (2009). Long-term follow-up of severe dysplasia and carcinoma in-situ of the bronchus. J Thorac Oncol, 4, 1187–1188.CrossRefPubMedGoogle Scholar
  40. 40.
    Hoshino, H., Shibuya, K., Chiyo, M., Iyoda, A., Yoshida, S., Sekine, Y., et al. (2004). Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Lung Cancer, 46, 187–196.CrossRefPubMedGoogle Scholar
  41. 41.
    Pasic, A., van Vliet, E., Breur, R. H., Risse, E. J., Snijders, P. J., Postmus, P. E., et al. (2004). Smoking behavior does not influence the natural course of pre-invasive lesions in bronchial mucosa. Lung Cancer, 45, 153–154.CrossRefPubMedGoogle Scholar
  42. 42.
    Banerjee, A. K. (2009). Preinvasive lesions of the bronchus. J Thorac Oncol, 4, 545–551.CrossRefPubMedGoogle Scholar
  43. 43.
    George, P., Banerjee, A., Read, C., O’Sullivan, C., Falzon, M., Pezzella, F., et al. (2007). Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax, 62, 43–50.CrossRefGoogle Scholar
  44. 44.
    Satoh, Y., Ishikawa, y, Nakagawa, K., Hirano, T., & Tsuchiya, E. (1997). A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers. British Journal of Cancer, 75, 678–683.PubMedGoogle Scholar
  45. 45.
    Jeanmart, M., Lantuejoul, S., Fievet, F., Moro, D., Sturm, N., Brambilla, C., et al. (2003). Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res, 9, 2195–2203.PubMedGoogle Scholar
  46. 46.
    Thieberville, L., Payne, P., Metayer, J., Vielkinds, J., LeRiche, J., Palcic, B., et al. (1997). Molecular follow-up of a pre-invasive bronchial lesion treated by a 13-cis-retinoic acid. Human Pathology, 28, 108–110.CrossRefGoogle Scholar
  47. 47.
    Helfritzsch, H., Junker, K., Bartel, M., & Scheele, J. (2002). Differentiation of positive autofluorescence bronchoscopy findings by comparative genomic hybridization. Oncol Rep, 9(4), 697–701.PubMedGoogle Scholar
  48. 48.
    Lam, S., MacAulay, C., leRiche, J. C., Dyachkova, Y., Coldman, A., Guillaud, M., et al. (2002). A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst, 94(13), 1001–1009.PubMedGoogle Scholar
  49. 49.
    Lam, S., Xu, X. C., Parker-Klein, H., LeRiche, J. C., MacAulay, C., Guillaud, M., et al. (2003). Surrogate endpoint biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. Int J Oncol, 23, 1607–1613.PubMedGoogle Scholar
  50. 50.
    Lam, S., leRiche, J. C., McWilliams, A., MacAulay, C., Dyachkova, Y., Szabo, E., et al. (2004). A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in persons with dysplasia of the bronchial epithelium. Clinical Cancer Research, 10, 6502–6511.CrossRefPubMedGoogle Scholar
  51. 51.
    Lam, S., McWilliams, A., Leriche, J., MacAulay, C., Wattenburg, L., & Szabo, E. (2006). A phase I study of myo-inositol for lung cancer chemoprevention. Cancer Epidemiology Biomarkers & Prevention, 15(8), 1526–1531.CrossRefGoogle Scholar
  52. 52.
    Wistuba, I. I., Lam, S., Behrens, C., Virmani, A. K., Fong, K. M., LeRiche, J., et al. (1997). Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst., 89, 1366–1373.CrossRefPubMedGoogle Scholar
  53. 53.
    Wistuba, I. I., Behrens, C., Milchgrub, S., Bryant, D., Hung, J., Minna, J. D., et al. (1999). Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene, 18, 643–650.CrossRefPubMedGoogle Scholar
  54. 54.
    Wistuba, I. I., Behrens, C., Virmani, Ak, Mele, G., Milchgrub, S., Girard, L., et al. (2000). High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Research, 60, 1949–1960.PubMedGoogle Scholar
  55. 55.
    Belinsky, S. A., Palmisano, W. A., Gilliland, F. D., Crooks, L. A., Divine, K. K., Winters, S. A., et al. (2002). Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Research, 62, 2370–2377.PubMedGoogle Scholar
  56. 56.
    Lamy, A., Sesboue, R., Bourguignon, J., Dautreaux, B., Metayer, J., Frebourg, T., et al. (2002). Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: A prospective study in high-risk patients without invasive cancer. International Journal of Cancer, 100, 189–193.CrossRefGoogle Scholar
  57. 57.
    Zöchbauer-Müller, S., Lam, S., Toyooka, S., et al. (2003). Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. International Journal of Cancer, 107, 612–616.CrossRefGoogle Scholar
  58. 58.
    Jonsson, S., Varella-Garcia, M., Miller, Y., Wolf, H. J., Byers, T., Braudrick, S., et al. (2008). Chromosomal aneusomy in bronchial high grade lesions is associated with invasive lung cancer. American Journal of Respiratory and Critical Care Medicine, 177, 342–347.CrossRefPubMedGoogle Scholar
  59. 59.
    Massion, P., Zou, Y., Uner, H., Kiatsimkul, P., Wolf, H. J., Baron, A. E., et al. (2009). Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS ONE, 4(6), e5611.CrossRefPubMedGoogle Scholar
  60. 60.
    Breuer, R., Snijders, P., Sutedja, T., vd Linden, H., Risse, E., Meijer, C., et al. (2003). Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer. Lung Cancer, 40, 165–172.CrossRefPubMedGoogle Scholar
  61. 61.
    Brambilla, E., Gazzeri, S., Lantuejoul, S., Coll, J. L., Moro, D., Negoescu, A., et al. (1998). p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res, 4, 1609–1618.PubMedGoogle Scholar
  62. 62.
    Brambilla, E., Gazzeri, S., Moro, D., Lantuejoul, S., Veyrene, S., & Brambilla, C. (1999). Alterations of RB pathway (RB-p16INKA4-cyclin D1) in pre-invasive bronchial lesions. Clin Cancer Res, 5, 243–250.PubMedGoogle Scholar
  63. 63.
    Lee, J. J., Liu, D., Lee, J. S., Kurie, J. M., Khuri, F. R., Ibarguen, H., et al. (2001). Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst, 93, 1081–1088.CrossRefPubMedGoogle Scholar
  64. 64.
    Tichelaar, J. W., Zhang, Y., leRiche, J. C., Biddinger, P. W., Lam, S., & Anderson, M. W. (2005). Increased staining for phosphor-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies. BMC Cancer, 5, 155. doi: 10.1186/1471-2407-5-155.CrossRefPubMedGoogle Scholar
  65. 65.
    Miyazu, Y., Miyazawa, T., Hiyama, K., Kurimoto, N., Iwamoto, Y., Matsuura, H., et al. (2005). Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Research, 65, 9623–9627.CrossRefPubMedGoogle Scholar
  66. 66.
    Sin, D. D., Man, S. F., McWilliams, A., & Lam, S. (2006). Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer. American Journal of Respiratory and Critical Care Medicine, 173, 535–539.CrossRefPubMedGoogle Scholar
  67. 67.
    Sin, D., Man, S., McWilliams, A., & Lam, S. (2008). Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer. Chest, 134(3), 582–588.CrossRefPubMedGoogle Scholar
  68. 68.
    Chen, J., Lam, S., Pilon, A., McWilliams, A., Macaulay, C., & Szabo, E. (2008). Higher levels of the anti-inflammatory protein CC10 are associated with improvement in bronchial dysplasia and sputum cytometric assessment in individuals at high risk for lung cancer. Clin Cancer Res, 14(5), 1590–1597.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Taichiro Ishizumi
    • 1
  • Annette McWilliams
    • 2
  • Calum MacAulay
    • 2
  • Adi Gazdar
    • 3
  • Stephen Lam
    • 2
    • 4
  1. 1.Department of Thoracic SurgeryTokyo Medical UniversityTokyoJapan
  2. 2.Department of Integrative OncologyBritish Columbia Cancer AgencyVancouverCanada
  3. 3.Hamon Center for Therapeutic Oncology & Department of PathologyUT Southwestern Medical CenterDallasUSA
  4. 4.Department of Integrative OncologyBritish Columbia Cancer Research CenterVancouverCanada

Personalised recommendations